Bendamustine and pneumocystis pneumonia: A systematic review.
Atousa HakamifardMasoud MardaniMohammad Javad NasiriTahereh Gholipur-ShahrakiPublished in: Health science reports (2022)
The present review described PCP infection in patients with malignancies after the treatment with bendamustine, a chemotherapeutic agent associated with lymphopenia. Further research is required to determine the PCP risk in patients with bendamustine treatment and identify individuals who may benefit from prophylaxis.